Literature DB >> 15350479

The spectrum of glomerular diseases in the kingdom of bahrain: an epidemiological study based on renal biopsy interpretation.

A Al Arrayed1, S M George, A K Malik, S Al Arrayed, S Rajagopalan, A Al Arrayed1, S E Sharqawi, K S Ratnakar, E Fareed, F Al Sabag.   

Abstract

Glomerular diseases continue to be the leading cause of end-stage renal disease globally. Hence it is important to recognize the glomerular disease pattern in any given geographical area to understand the pathobiology in the region as well as the incidence and progression of the disorder. A total of 498 renal biopsies were performed on patients with proteinuria, hematuria, and mild to moderate renal impairment during a period of 13 years (between January 1990 and December 2002) at a tertiary care hospital. Primary glomerular disease accounted for two-thirds of the glomerular diseases, which was 44.8% of all renal biopsies. The most common histological lesion was minimal change disease (30%). Focal segmental glomerulosclerosis was the second most common lesion (23.8%) followed by membranoproliferative glomerulonephritis (14.3%). Secondary glomerular disease included 33.6% of glomerular diseases with 22.7% with lupus nephritis as the commonest lesion (38.9%) followed by diabetic nephropathy (31.9%) and hypertension (20.4%). Tubulointerstitial diseases accounted for 13.1% of all renal biopsies, whereas transplant diseases were noted in 12.2%. The miscellaneous group including inadequate biopsies, which constituted 7.2% of all the tissues. The results of this analysis were compared with surveys from other parts of the world.

Entities:  

Mesh:

Year:  2004        PMID: 15350479     DOI: 10.1016/j.transproceed.2004.07.027

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

1.  Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011.

Authors:  Dita Maixnerova; Eva Jancova; Jelena Skibova; Romana Rysava; Ivan Rychlik; Ondrej Viklicky; Miroslav Merta; Alexander Kolsky; Jana Reiterova; Michaela Neprasova; Jana Kidorova; Eva Honsova; Vladimir Tesar
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

2.  Renal biopsy findings in Iran: case series report from a referral kidney center.

Authors:  Shahrzad Ossareh; Mojgan Asgari; Ezatollah Abdi; Hosein Nejad-Gashti; Yousef Ataipour; Sasan Aris; Fereidoon Proushani; Ghodratollah Ghorbani; Fatemeh Hayati; Ahad J Ghods
Journal:  Int Urol Nephrol       Date:  2010-01-06       Impact factor: 2.370

3.  The spectrum of glomerular diseases on renal biopsy: data from a single tertiary center in oman.

Authors:  Dawood Al Riyami
Journal:  Oman Med J       Date:  2013-05

4.  Glomerular diseases in the Military Hospital of Morocco: Review of a single centre renal biopsy database on adults.

Authors:  T Aatif; O Maoujoud; D I Montasser; M Benyahia; Z Oualim
Journal:  Indian J Nephrol       Date:  2012-07

5.  Pattern of biopsy-proven renal disease in a single center of south India: 19 years experience.

Authors:  U Das; K V Dakshinamurty; A Prayaga
Journal:  Indian J Nephrol       Date:  2011-10

6.  Pattern of biopsy proven renal diseases at PNS SHIFA, Karachi: A cross-sectional survey.

Authors:  Sohail Sabir; Muhammed Mubarak; Irfan Ul-Haq; Aisha Bibi
Journal:  J Renal Inj Prev       Date:  2013-10-10

7.  A study of primary glomerular diseases in adults; clinical, histopathological and immunofluorescence correlations.

Authors:  Ananta Satya Narayana Modugumudi; Phaneendra Bobbidi Venkata; Siva Kumar Vishnu Bottla; Radhika Kottu; Rukmangadha Nandyala; Rashmi Patnayak; Amit Kumar Chowhan; Lakshmi Amancharla Yadgiri
Journal:  J Nephropharmacol       Date:  2015-10-03

8.  Glomerulonephritis Pattern at a Jordanian Tertiary Care Center.

Authors:  Randa I Farah
Journal:  Int J Nephrol       Date:  2018-10-11

9.  A Systematic Review and Meta-analysis of Prevalence of Biopsy-Proven Lupus Nephritis.

Authors:  Hong Wang; Yi-le Ren; Jun Chang; Luo Gu; Ling-Yun Sun
Journal:  Arch Rheumatol       Date:  2017-07-25       Impact factor: 1.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.